1,313
Views
18
CrossRef citations to date
0
Altmetric
Original Article

In vitro susceptibility of the Gram-negative bacterium Helicobacter pylori to extracts of Iranian medicinal plants

, , , , , , & show all
Pages 77-80 | Received 05 Dec 2007, Accepted 23 Jun 2008, Published online: 01 Jan 2009

References

  • Bergonzelli GE, Donnicola D, Porta N, Corthesy-Theulaz IE (2003), Essential oils as components of a diet-based approach to management of Helicobacter infection. Antimicrob Agents Chemother 47, 3240–3246.
  • Bytzer P, O’Morain C (2005), Treatment of Helicobacter pylori. Helicobacter 10 (Suppl. 1), 40–46.
  • Foroumadi A, Asadipour A, Arabpour F, Amanzadeh Y (2002), Composition of the essential oil of Bunium persicum (Bioss.) B. Fedtsch. from Iran. J Essent Oil Res 14, 161–162.
  • Graham DY, Qureshi WA (2000), Antibiotic resistant H. pylori infection and its treatment. Curr Pharmacol Des 6, 1537–1544.
  • Hoffman BR, DelasAlas H, Blanco K, Wiederhold N, Lewis RE, Williams L (2004), Screening of antibacterial and antifungal activities of ten medicinal plants from Ghana. Pharm Biol 42, 13–17.
  • Li Y, Xu C, Zhang Q, Liu JY, Tan RX (2005), In vitro anti-Helicobacter pylori action of 30 Chinese herbal medicine used to treat ulcer diseases. J Ethnopharmacol 98, 329–333.
  • Mahady GB, Pendland SL, Stoia A, Hamill F, Fabricant D, Dietz BM, Chadwick LR (2005), In vitro susceptibility of Helicobacter pylori to botanical extracts used traditionally for the treatment of gastrointestinal disorders. Phytother Res 19, 988–991.
  • Malekzadeh F, Ehsanifar H, Shahamat M, Levin M, Colwell RR (2001), Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int J Antimirob Agents 18, 85–88.
  • Mansouri S, Foroumadi A, Ghaneie T, Gholamhosseinian NajarA (2001), Antibacterial activity of the crude extracts and fractionated constituents of Myrtus communis. Pharm Biol 39, 399–401.
  • Nariman F, Eftekhar F, Habibi Z, Falsafi T (2004), Anti-Helicobacter pylori activities of six Iranian plants. Helicobacter 9, 146–151.
  • NCCLS (1998), Methods for Antimicrobial Susceptibility Testing for Bacteria that Grow Aerobically; Approved Standard, 4th ed. NCCLS document M7-A4. Wayne, PA, National Committee for Clinical Laboratory Standards.
  • Nostro A, Cellini L, Di Bartolomeo S, Di Campli E, Grande R, Cannatelli MA, Marziol L, Alonzo V (2005), Antibacterial effect of plant extracts against Helicobacter pylori. Phytother Res 19, 198–202.
  • Stamatis G, Kyriazopoulos P, Golegou S, Basayiannis A, Skaltsas S, Skaltsa XH (2003), In vitro anti-Helicobacter pylori activity of Greek herbal medicines. J Ethnopharmacol 88, 175–179.
  • Wang YC, Huang TL (2005), Screening of anti-Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol 43, 295–300.
  • Williamson JS (2001), Helicobacter pylori: Current chemotherapy and new targets for drug design. Curr Pharm Des 7, 355–392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.